More recently, SRC activation was shown to increase YAP/TAZ activity by repressing LATS in breast cancer and melanoma cells through inactivation of GPCR-kinase-interacting protein 1 (GIT1), which, in turn, promotes the LATS-mediated phosphorylation of YAP [47]. This evidence concerns the gene YAP1 and breast cancer.